Real-world data on the effectiveness, safety and drug survival of dupilumab: an analysis from the TREATgermany registry

Stoelzl D, Sander N, Heratizadeh A, Haufe E, Harder I, Abraham S, Heinrich L, Kleinheinz A, Wollenberg A, Weisshaar E, Schaekel K, Ertner K, Wiemers F, Wildberger J, Worm M, Von Kiedrowski R, Effendy I, Asmussen A, Augustin M, Pawlak M, Sticherling M, Zink A, Hilgers M, Handrick C, Quist S, Schwarz B, Staubach-Renz P, Bell M, Hong-Weldemann SH, Homey B, Bruecher JJ, Schmitt J, Werfel T, Weidinger S (2022)

Publication Type: Journal article

Publication year: 2022

Journal

British Journal of Dermatology Wiley-Blackwell

DOI: 10.1111/bjd.21794

Authors with CRIS profile

Michael Sticherling Professur für Dermatologie

Involved external institutions

Technische Universität Dresden DE Germany (DE) Universitätsklinikum Schleswig-Holstein (UKSH) DE Germany (DE) Medizinische Hochschule Hannover (MHH) / Hannover Medical School DE Germany (DE)

How to cite

APA:

Stoelzl, D., Sander, N., Heratizadeh, A., Haufe, E., Harder, I., Abraham, S.,... Weidinger, S. (2022). Real-world data on the effectiveness, safety and drug survival of dupilumab: an analysis from the TREATgermany registry. British Journal of Dermatology. https://dx.doi.org/10.1111/bjd.21794

MLA:

Stoelzl, Dora, et al. "Real-world data on the effectiveness, safety and drug survival of dupilumab: an analysis from the TREATgermany registry." British Journal of Dermatology (2022).

BibTeX: Download